{"schema":"sb.node.v1","id":"sb:e/d81f57497bfb9392eac83341","kind":"entity","label":{"text":"cfr part","locale":"en"},"identity":{"anchor":"label:en:cfr part","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-08T19:01:28.512480+00:00","snapshot":"deploy 8dd9d123c0c014cc0feb12d9cad07a8bb73606c6"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":47,"separatePublishers":23,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-06-30","to":"2026-10-07","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.106: about 89% of mentions carry no typed assertion"]}},"dimensions":{"domains":["biotech_pharma","nuclear_energy","auto"],"activeDays":26,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":12,"byKind":{"observation":12},"items":[{"id":"sb:o/84f15c26c77f52522c6815e7","kind":"observation","label":"FDA · 2026-10-07 · TCI Co., Ltd BioCosme PABP BRANCH - 736888 - 09/02/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tci-co-ltd-biocosme-pabp-branch-736888-09022026"},{"id":"sb:o/355f98848396fbafb045bbb6","kind":"observation","label":"FDA · 2026-10-07 · Pine Pharmaceuticals, LLC - 728537 - 08/07/2026","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pine-pharmaceuticals-llc-728537-08072026"},{"id":"sb:o/f889e63061c36e57c456db23","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-07 · FDA’s Advisory Committee Rebuild Will Reshape Protocol Feedback Before Sponsors Realize It","url":"https://www.clinicaltrialvanguard.com/clinical-trial-ops-brief/fdas-advisory-committee-rebuild-will-reshape-protocol-feedback-before-sponsors-realize-it/"},{"id":"sb:o/4257a1b528a4fb7911c9a569","kind":"observation","label":"Marine Link · 2026-10-07 · Cyber Security: To Serve and Connect","url":"https://www.marinelink.com/news/cyber-security-serve-connect-543522"},{"id":"sb:o/4e24b7bcd893530897ff2b7a","kind":"observation","label":"analyticsinsight · 2026-10-06 · eIFU Requirements in 2026: FDA eLabeling, EU MDR and the 2025 Amendment, Plus 8 eIFU Services Compared","url":"https://www.analyticsinsight.net/technology/eifu-requirements-in-2026-fda-elabeling-eu-mdr-and-the-2025-amendment-plus-8-eifu-services-compared"},{"id":"sb:o/f197317ea1c1144ceb9da677","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-06 · The Infrastructure Bet That Pays Off Before the First Patient Enrolls","url":"https://www.clinicaltrialvanguard.com/executiveinterviews/the-infrastructure-bet-that-pays-off-before-the-first-patient-enrolls/"},{"id":"sb:o/d4fa561650c462cf8172c74f","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-06 · Novo’s Denecimig Got a Green Light From Clinicians and a Red Light From an Inspector: Who Failed?","url":"https://www.clinicaltrialvanguard.com/clinops-watchdog/novos-denecimig-got-a-green-light-from-clinicians-and-a-red-light-from-an-inspector-who-failed/"},{"id":"sb:o/11a8536de4d3b93ff4c2fd5d","kind":"observation","label":"FDA · 2026-10-06 · Glenmark Pharmaceuticals Limited - 637314 - 11/22/2022","url":"http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glenmark-pharmaceuticals-limited-637314-11222022"},{"id":"sb:o/3d3d7e99af045ec791c737b8","kind":"observation","label":"ANS Nuclear Newswire · 2026-10-06 · Details emerge on Valar’s Utah plans","url":"https://www.ans.org/news/2026-10-05/article-8462/details-emerge-on-valars-utah-plans/"},{"id":"sb:o/56b4e5e2bf7e126a01ebbe55","kind":"observation","label":"AZoM · 2026-10-05 · Granutools Launches the New GranuDrum More Automation | Faster Results | Higher Accuracy","url":"https://www.azom.com/news.aspx?newsID=65872"}],"cursor":"c1.eyJpZCI6InNiOmUvZDgxZjU3NDk3YmZiOTM5MmVhYzgzMzQxIiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTA4VDE5OjAxOjI4LjUxMjQ4MCswMDowMCJ9","order":"newest first; we keep the 12 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with united states (22 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/bdc80ec1806cdec92f57cd0e"},{"kind":"relation","label":"co-mentioned with fda (19 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/abe6a611a92428f492272fba"},{"kind":"relation","label":"co-mentioned with u.s.c (16 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/79726f870eb256b04ae1ba12"},{"kind":"relation","label":"co-mentioned with cosmetic act (15 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/90c4e7cf5b147f68300e3a26"},{"kind":"relation","label":"co-mentioned with fd&c act (15 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/d33b702be7bb80aa34c55f32"},{"kind":"relation","label":"co-mentioned with federal food (15 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/85bc8cd4add42f63256dfb43"},{"kind":"relation","label":"co-mentioned with drug administration (14 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/4c22577060e4c6eb44440d7e"},{"kind":"relation","label":"co-mentioned with cms (13 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/bb7605559dbdcdfa07fe9472"},{"kind":"relation","label":"co-mentioned with warning letter (13 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/eaf7f25daeb7d7da0cf304a7"},{"kind":"relation","label":"co-mentioned with cder (13 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/88abc5cda3504ad1bda4a43b"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/d81f57497bfb9392eac83341","mcp":"traverse {\"id\":\"sb:e/d81f57497bfb9392eac83341\"}","page":"/entity/cfr-part/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/d81f57497bfb9392eac83341\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/d81f57497bfb9392eac83341\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/d81f57497bfb9392eac83341\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/d81f57497bfb9392eac83341\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}